Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03293316

Ligand	Ligand name	Chain	PDB	Tanimoto
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.71
RCL	RICINOLEIC ACID	A	2CM4	0.73
RCL	RICINOLEIC ACID	A	2CM9	0.73
RCL	RICINOLEIC ACID	A	1FK7	0.73
MRC	MUPIROCIN	A	1JZS	0.71
MRC	MUPIROCIN	A,T	1FFY	0.71
MRC	MUPIROCIN	A	1QU3	0.71
MRC	MUPIROCIN	A,T	1QU2	0.71
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.71
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.71
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.75
EB1	SEOCALCITOL	A	1S0Z	0.71
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.74
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.72
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.73
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.73
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.73
803	LOVASTATIN	A,B	1CQP	0.7
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.7
114	COMPACTIN	A,B,C,D	1HW8	0.7
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.82
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.73
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.71
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.72
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.73
E2P	PROSTAGLANDIN B2	A	1CZ2	0.72
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.7
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.74
FUG	FUMAGILLIN	A,B	3FMQ	0.73
FUG	FUMAGILLIN	A	1BOA	0.73
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.84
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.81
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.81
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.81
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.71
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.7
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.71
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.73
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.75
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.75
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.86
MEI	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	A,B	1UHL	0.74
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.76